Outpatient Administration of Teclistamab for Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
This study is looking at how a new medicine called Teclistamab can be given to patients with a type of cancer called multiple myeloma. The study is in the second phase, which means it is testing if the medicine is safe and effective outside of the hospital. Researchers want to see if patients can take the medicine at home instead of staying in the hospital for treatment.
This study is looking at how a new medicine called Teclistamab can be given to patients with a type of cancer called multiple myeloma. The study is in the second phase, which means it is testing if the medicine is safe and effective outside of the hospital. Researchers want to see if patients can take the medicine at home instead of staying in the hospital for treatment.
*Third Opinion AI Generated Synopsis
Trial Summary
This is a phase II study to evaluate the Outpatient Administration of Teclistamab in Multiple Myeloma Patients
This is a phase II study to evaluate the Outpatient Administration of Teclistamab in Multiple Myeloma Patients
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: